PEPFAR's treatment programs provide essential medications to more than two million people. PEPFAR also contributes to the strengthening of the health systems needed to deliver these drugs in low-resource settings. In addition, PEPFAR serves populations with special treatment needs, like children. Together, all global efforts support approximately four million people on antiretroviral treatment, but at least five million more are still in need of ARV drugs. This figure will likely double with the recent revision of WHO recommendations for treatment initiation. As part of its reauthorization, PEPFAR was charged with supporting increased treatment commensurate with increased appropriations and efficiencies realized. PEPFAR's treatment strategy over the next five years emphasizes the following activities:
Progress Achieved through September 30, 2009:
For more information on PEPFAR's data collection, please visit: www.pepfar.gov/2009results/.
Programmatic Strategy: In this second phase of PEPFAR, a new program strategy is underway that supports the Administration's overall emphasis on improving health outcomes, increasing program sustainability and integration, and strengthening health systems. Some of these changes are already being implemented with planning and programming for FY 2010. Over the next year, PEPFAR will be working closely with country teams in order to translate, prioritize, and implement this strategy in a manner appropriate to the country context. More information on the broader strategic framework for PEPFAR activities can be found in the strategy annexes which will be made available at www.pepfar.gov/strategy.
| U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator|
and the Bureau of Public Affairs, U.S. State Department.
External Link Policy | Copyright Information | Privacy | FOIA